Skip to content

Originally published in Stephen Dover’s LinkedIn Newsletter, Global Market Perspectives. Follow Stephen Dover on LinkedIn where he posts his thoughts and comments as well as his Global Market Perspectives newsletter.

As expected, the “Big Beautiful Bill” (BBB) has cleared its final legislative hurdles and will soon be signed into law by US President Trump. In what follows, we assess the implications for global capital markets and investment strategy.

In sum, and in the parlance of credit markets, we would dub the new law is “investment grade”—BBB or even higher. To be sure, the market has long anticipated much of the legislation’s provisions, and therefore we believe the positive impacts are more likely to be felt over time rather than in a single large move.

Nevertheless, the initial market reaction has been positive, with US equities, Treasury yields and the US dollar moving higher. Largely, that outcome reflects the removal of uncertainty, a plus for investors. While the odds that the bill would not pass were always remote, investors can now plan with some confidence about US taxation and spending.

It is also worth underscoring more durable positive aspects of the BBB.

  • While the statutory corporate income tax rate of 21% remains the same, provisions for accelerated depreciation will reduce the effective corporate tax rate to as low as 14%–15% for the median firm. Not only will that help promote capital expenditures, the reduction in the tax burden should also help offset some probable margin pressure from companies unable to fully pass along higher import costs from tariffs. Small- and mid-cap firms are most likely to benefit from the reduction in effective tax rates, in our analysis.
  • Reduced uncertainty, alongside improved after-tax profits (and cash flows), may revive moribund mergers and acquisitions and initial public offerings, which would potentially provide a lift to financials and alternatives.
  • Tax relief without corresponding spending reductions suggests the legislation will likely support the economy via a modest form of fiscal stimulus. In addition, the favorable tax treatment of capital expenditures depreciation should boost business outlays. From a macroeconomic perspective, the estimated contribution to US real gross domestic product (GDP) growth is probably in the range of 0.2%–0.3% over the coming year, with some drag occurring from higher tariffs and smaller transfer payments (e.g., Medicaid and welfare cuts), where negative multiplier effects are apt to be significant.
  • By market sector, the beneficiaries of accelerated depreciation and higher capital expenditures include information technology (given its leading role in innovation), industrials and pharmaceuticals. Together with higher tariffs, which will likely incentivize manufacturing investment in the United States, the prospects for capital spending have brightened, reflecting a trend already evident in announcements from various firms in the semiconductor (including via a 35% tax credit), industrials and autos sectors.
  • The removal of Section 899 provisions to implement stepped up taxation for tax residents of countries deemed to impose “unfair” taxes on US businesses is a significant plus and reinforces the structural attractiveness of US capital markets.

Conversely, here are some potential less favorable aspects:

  • The biggest losers are the solar and wind subsectors of alternative energy (hydrogen and nuclear retain favorable tax and investment treatment). That said, the imposition of new taxes on solar was removed from the final version of the legislation.
  • The legislation ensures the continuation of large US fiscal deficits over the coming years. According to fiscal scoring from the independent Congressional Budget Office (CBO), the increase in US debt over the next 10 years from the legislation will range from $2.4 trillion–$3 trillion. Thus far, the US Treasury market has responded with equanimity, partly reflecting cyclical expectations for moderating inflation and subdued economic activity in 2025. Over time, however, we believe larger US deficits, higher capital expenditures and fiscal expansion elsewhere (e.g., in Germany or China) will likely put upward pressure on global real interest rates.

On balance, therefore, the BBB legislation is, in our opinion, justifiably being greeted with an “investment grade” from the capital markets. It may not be AAA, but we believe the bill should help underpin the positive momentum in markets underway since mid-April.



Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.